Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality

NACompletedINTERVENTIONAL
Enrollment

15,965

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

December 31, 2022

Conditions
Cardiovascular DiseasesIntensity CareMorality
Interventions
OTHER

AI-enabled ECG-based Screening Tool

Primary care clinicians in the intervention group had access to the report, which shows the risk prediction results for each patients. Moreover, the clinicians will recieve a short message when patients with a high risk ECG identified by AI.

Trial Locations (1)

114

National Defense Medical Center, Taipei

All Listed Sponsors
lead

National Defense Medical Center, Taiwan

OTHER

NCT05118035 - Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality | Biotech Hunter | Biotech Hunter